These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3771110)

  • 1. The use of desmopressin in children with coagulation disorders.
    Brown OE
    Int J Pediatr Otorhinolaryngol; 1986 Sep; 11(3):301-5. PubMed ID: 3771110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin: a nontransfusional hemostatic agent.
    Mannucci PM
    Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
    Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
    Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
    [No Abstract]   [Full Text] [Related]  

  • 5. Desmopressin (DDAVP) in bleeding disorders of childhood.
    Sutor AH
    Semin Thromb Hemost; 1998; 24(6):555-66. PubMed ID: 10066151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
    Mannucci PM
    Blood; 1988 Nov; 72(5):1449-55. PubMed ID: 3052622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
    Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
    Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin (DDAVP) and hemostasis.
    Lethagen S
    Ann Hematol; 1994 Oct; 69(4):173-80. PubMed ID: 7948303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of desmopressin in the management of two patients with von Willebrand's disease undergoing periodontal surgery. 2 case reports.
    Petrover MG; Cohen CI
    J Periodontol; 1990 Apr; 61(4):239-42. PubMed ID: 2324924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desmopressin in the treatment of hemorrhagic diathesis].
    Haar D; Hasselbalch HC
    Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP in the treatment of bleeding disorders.
    Salva KM; Kim HC; Nahum K; Fallot PL
    Pharmacotherapy; 1988; 8(2):94-9. PubMed ID: 3041385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
    Lethagen S; Ragnarson Tennvall G
    Ann Hematol; 1993 May; 66(5):257-60. PubMed ID: 8507721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
    Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
    Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
    Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
    Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative management of patients with von Willebrand's disease.
    Cameron CB; Kobrinsky N
    Can J Anaesth; 1990 Apr; 37(3):341-7. PubMed ID: 2182206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.